A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
收藏NIAID Data Ecosystem2026-04-25 收录
官方服务：
资源简介：
Patients were ages 18 years or older with metastatic or recurrent/refractory HPV-16-associated cancer. Patients may have received any prior lines of therapy or declined standard therapy. Patients must be HLA-A*02:01-positive.]]>
创建时间：
2020-11-02
